Olais, Jodalyn .
HRN: 26-02-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CEFUROXIME 500MG (TAB)
10/12/2024
10/18/2024
PO
1tab
Bid
Nsvd UTI
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes